|
2006 Conference Publication Increased acetaminophen hepatotoxicity in the NaS1 and Sat1 sulfate transporter null miceLee, S, Dawson, P A, Hewavitharana, A, Shaw, P N and Markovich, D (2006). Increased acetaminophen hepatotoxicity in the NaS1 and Sat1 sulfate transporter null mice. ComBio2006, Brisbane / Brisbane Convention Centre, 24-28 September 2006. Brisbane: Australian Physiological Society. |
|
2006 Conference Publication Hyposulfataemia and gastrointestinal physiologyDawson, P A, Strachan, A J, Huxley,, Mcguckin, M. A. and Markovich, D (2006). Hyposulfataemia and gastrointestinal physiology. |
|
2006 Conference Publication Profiling acetaminophen metabolites in mouse urine by LC-MS-MSShaw, P N, Hewavitharana, A, Lee, S, Dawson, P A and Markovich, D (2006). Profiling acetaminophen metabolites in mouse urine by LC-MS-MS. British Pharmaceutical Conference, Manchester UK / Mancester International Convention Centre, 4-6 September 2006. Belfast, Northern Ireland: Pharmaceutical Press. |
|
2006 Conference Publication Profiling acetaminophen metabolites in mouse urine by LC-MS-MSShaw, P. N., Hewavitharana, A. K., Lee, S., Dawson, P. and Markovich, D. (2006). Profiling acetaminophen metabolites in mouse urine by LC-MS-MS. The British Pharmaceutical Conference, Manchester, England, 4-6 September 2006. West Sussex, England, U.K.: John Wiley & Sons Ltd.. doi: 10.1211/002235706778251375 |
|
2005 Conference Publication Sulphate ions in mammalian physiology: lessons from sulphate transporter knock-out miceDawson, P. A., Gardiner, B., Lee, S., Ku, and Markovich, D. (2005). Sulphate ions in mammalian physiology: lessons from sulphate transporter knock-out mice. AuPS/ASB Canberra 2005 Meeting, Canberra Rydges Lakeside Hotel, 27-30 September. Canberra: ANU. |
|
2005 Conference Publication Altered metabolism and lifespan in the NAs1 sulfate transporter null mouseDawson, P. A. and Markovich, D. (2005). Altered metabolism and lifespan in the NAs1 sulfate transporter null mouse. ComBio2005 Combined Conference, Adelaide S.A., 25-29 Sept 2005. South Australia: Australian Society for Biochemistry and Molecular Biology, Inc.. |
|
2005 Conference Publication Increased acetaminophen hepatotoxicity in the NaS1 sulphate transporter null mouseLee, K, Dawson, P. A. and Markovich, D. (2005). Increased acetaminophen hepatotoxicity in the NaS1 sulphate transporter null mouse. AuPS/ASB Canberra 2005 Meeting, Canberra Rydges Lakeside Hotel, 27-30 Sept, 2005. Canberra: Australian Physiological Society. |
|
2000 Conference Publication Development of a mutation suppression approach to the gene therapy of osteogenesis imperfectaForlino, A., Dawson, P. A., Lisi, and Marini, J. C. (2000). Development of a mutation suppression approach to the gene therapy of osteogenesis imperfecta. Unknown, Unknown, Unknown. New York, NY United States: Nature Publishing Group. |
|
1999 Conference Publication Development of gene therapy for osteogenesis imperfecta using hammerhead ribozymes and a knock-in mouse model of OIMarini, Joan C., Forlino, Antonella and Dawson, Paul A. (1999). Development of gene therapy for osteogenesis imperfecta using hammerhead ribozymes and a knock-in mouse model of OI. The American Pediatric Society and The Society for Pediatric Research 1999 annual meeting, San Francisco, CA USA, 1-4 May 1999. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1203/00006450-199904020-00828 |
|
1998 Conference Publication Selective Suppression of Mutant Type I Collagen mRNA in Cultured Osteogenesis Imperfecta Fibroblasts: Development of Gene Therapy for Dominant Disorders • 708Dawson, Paul A. and Marini, Joan C. (1998). Selective Suppression of Mutant Type I Collagen mRNA in Cultured Osteogenesis Imperfecta Fibroblasts: Development of Gene Therapy for Dominant Disorders • 708. The American Pediatric Society and The Society for Pediatric Research Conference 1998, -, 1998. London, United Kingdom: Nature Publishing Group. doi: 10.1203/00006450-199804001-00729 |
|
1998 Conference Publication Ribozyme suppression of mutant type T collagen mRNA in cultured OI fibroblasts: development of gene therapy for dominant disordersDawson, P. A. and Marini, J. C. (1998). Ribozyme suppression of mutant type T collagen mRNA in cultured OI fibroblasts: development of gene therapy for dominant disorders. Unknown, Unknown, Unknown. JENA: GUSTAV FISCHER VERLAG. doi: 10.1016/S0945-053X(98)90041-5 |
|
1997 Conference Publication Extension of phenotype associated with structural mutations in type I collagen: Siblings with juvenile osteoporosis have an alpha 2(I)gly436 -> arg substitutionKelly, T. E., Dawson, P. A. and Marini, J. C. (1997). Extension of phenotype associated with structural mutations in type I collagen: Siblings with juvenile osteoporosis have an alpha 2(I)gly436 -> arg substitution. -, -, -. Cambridge, MA United States: Cell Press. |
